MAbSilico invited to participate to the "Writing the future of drug discovery & development" webinar sessions organized by Twist Bioscience.
The webinar details a collaborative project performed by MAbSilico and GlycoFormA (Wichita, KS, United States). It covers
- a discussion on the use of therapeutic antibodies for gynaecology and endocrinology.
- the use of MAbTope, our in silico epitope mapping tool, to characterize GlycoFormA antibody.
- how Twist Bioscience technology was used to generate the FSH constructs which were used to validate the prediction in the wet-lab